Skip to content
OpenCapital
Get started

Pacific Biosciences of California PACB Asia-Pacific — Total Revenue

Other geography segments

Americas
$16.69M+2.3%
Europe, Middle East and Africa
$10.77M+16.5%

Similar metrics at other companies

Illumina logo
ILMNAsia-Pacific — Total Revenue
$93M+13.4%
UiPath logo
PATHAsia-Pacific — Total Revenue
$81.5M+13.9%
GitLab logo
GTLBAsia Pacific — Total Revenue
$6.59M+45.0%
Progress Software logo
PRGSAsia Pacific — Total Revenue
$11.2M-1.5%
Maravai LifeSciences Holdings, Inc. logo
MRVIAsia Pacific — Revenue
$7.87M-25.4%
Arteris, Inc. logo
AIPAsia Pacific — Total Revenue
$8.4M+20.8%

Other financials

Income statement

See full
Revenue$37.2M+0.1%
Gross profit$12.8M+1,037%
Operating income-$8.4M+98.1%
Net income-$8.3M+98.1%
EPS (diluted)-$0.03+97.9%

Balance sheet

See full
Cash & equivalents$57.9M-4.7%
Total debt$59.3M+12.1%
Total equity$2.4M-97.4%
Total assets$782.4M-9.1%

Cash flow

See full
Operating cash flow-$44.7M-1.4%
CapEx$3.0M+119%
Free cash flow-$47.7M-5.0%

Valuation

See full
Market cap$496.96M+30.4%
Enterprise value$498.38M+33.5%
P/S3.1×+0.6×

Profitability

See full
Gross margin37.5%+21.3pp
Operating margin-83.3%-38.2pp
Net margin-80.3%-36.1pp
FCF margin-72.6%-20.0pp

Returns & leverage

See full
Return on equity-273.6%+314pp
Debt / equity25.1×+24.5×
Current ratio5.7×-1.0×

Where this comes from

Reported directly by Pacific Biosciences of California in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax.

The official record: Pacific Biosciences of California’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Pacific Biosciences of California's asia-pacific — total revenue.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Pacific Biosciences of California's asia-pacific — total revenue?
Pacific Biosciences of California (PACB) reported asia-pacific — total revenue of $9.72M in Q1 2026.
How has Pacific Biosciences of California's asia-pacific — total revenue changed year-over-year?
Pacific Biosciences of California's asia-pacific — total revenue decreased by 16.2% year-over-year, from $11.61M to $9.72M.
What is the long-term trend for Pacific Biosciences of California's asia-pacific — total revenue?
Over 4 years (2021 to 2025), Pacific Biosciences of California's asia-pacific — total revenue has grown at a 4.8% compound annual growth rate (CAGR), from $35.72M to $43.16M.
What does asia-pacific — total revenue mean?
This metric represents the total gross revenue generated from the sale of genetic sequencing platforms, consumables, and related services within the Asia-Pacific geographic region. It serves as a key indicator of the company's market penetration, adoption rates of sequencing technology, and competitive positioning in this specific international market. Tracking this revenue stream helps investors assess the company's ability to scale its global footprint and capture demand in emerging biotechnology sectors across Asia.